A Phase 1 Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of TERN-701 in Participants with Chronic Myeloid Leukemia

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2023-507677-18-00

Acronym

TERN701-1012

Enrollment

Registered

2024-04-22

Start date

2024-05-17

Completion date

Unknown

Last updated

2025-09-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Myeloid Leukemia

None listed

Sex/Gender

All

Age

18 Years to 64 Years

France, Germany, Italy, Spain

None listed

Source: EU CTIS · Data processed: Feb 4, 2026